Patient Safety Organizations: Voluntary Relinquishment for the Chicago Breast Cancer Quality Consortium, 53658-53659 [2021-21072]
Download as PDF
<![CDATA[
53658
Federal Register / Vol. 86, No. 185 / Tuesday, September 28, 2021 / Notices
Freedom of Information Office at
https://www.federalreserve.gov/foia/
Sunshine Act Meeting
request.htm. Interested persons may
express their views in writing on the
TIME AND DATE: Thursday, September 30,
standards enumerated in the BHC Act
2021 at 10:00 a.m.
(12 U.S.C. 1842(c)).
PLACE: Virtual meeting. Note: Because of
Comments regarding each of these
the Covid-19 pandemic, we will
applications must be received at the
conduct the open meeting virtually. If
Reserve Bank indicated or the offices of
you would like to access the meeting,
the Board of Governors, Ann E.
see the instructions below.
Misback, Secretary of the Board, 20th
STATUS: This meeting will be open to the Street and Constitution Avenue NW,
public. To access the virtual meeting, go Washington DC 20551–0001, not later
to the commission’s website
than October 28, 2021.
www.fec.gov and click on the banner to
A. Federal Reserve Bank of
be taken to the meeting page.
Minneapolis (Chris P. Wangen,
Assistant Vice President), 90 Hennepin
MATTERS TO BE CONSIDERED:
Avenue, Minneapolis, Minnesota
Draft Advisory Opinion 2021–09:
55480–0291:
Certified Voter
1. Frandsen Financial Corporation,
Statement of Reasons in Support of
Arden Hills, Minnesota; to acquire Bank
Repayment Determination After
Administrative Review—Dr. Jill Stein, of Zumbrota, Zumbrota, Minnesota and
Pine Island Bank, Pine Island,
Jill Stein for President (LRA #1021)
Campaign Guide for Congressional
Minnesota.
Candidates and Committees
B. Federal Reserve Bank of Kansas
Management and Administrative
City (Jeffrey Imgarten, Assistant Vice
Matters
President) 1 Memorial Drive, Kansas
CONTACT PERSON FOR MORE INFORMATION: City, Missouri 64198–0001:
1. First Western Financial, Inc.,
Judith Ingram, Press Officer ,Telephone:
Denver, Colorado; to merge with Teton
(202) 694–1220.
Financial Services, Inc., Wilson,
(Authority: Government in the Sunshine Act,
Wyoming, and thereby indirectly
5 U.S.C. 552b)
acquire Rocky Mountain Bank, Jackson,
Vicktoria J. Allen,
Wyoming.
FEDERAL ELECTION COMMISSION
Acting Deputy Secretary of the Commission.
[FR Doc. 2021–21119 Filed 9–24–21; 11:15 am]
BILLING CODE 6715–01–P
[FR Doc. 2021–21028 Filed 9–27–21; 8:45 am]
FEDERAL RESERVE SYSTEM
BILLING CODE P
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
VerDate Sep<11>2014
16:35 Sep 27, 2021
Jkt 253001
Board of Governors of the Federal Reserve
System, September 23, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
FEDERAL RETIREMENT THRIFT
INVESTMENT BOARD
Notice of Employee Thrift Advisory
Council Meeting
October 19, 2021 at 10 a.m.
Telephonic. Dial-in (listen
only) information: Number: 1–415–527–
5035, Code: 2764 577 0210; or via web:
https://tspmeet.webex.com/tspmeet/
onstage/g.php?MTID=e93b203932e7
c4905279e93a87109ab84.
FOR FURTHER INFORMATION CONTACT:
Kimberly Weaver, Director, Office of
External Affairs, (202) 942–1640.
SUPPLEMENTARY INFORMATION:
DATES:
ADDRESSES:
Meeting Agenda
1. Approval of the May 26, 2021 Joint
Board/ETAC Meeting Minutes
2. Thrift Savings Fund Statistics
3. Legislative Update
4. FY2022 FRTIB Budget
5. Participant Satisfaction Report
6. Converge Update
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
7. New Business
Authority: 5 U.S.C. 552b(e)(1).
Dated: September 22, 2021.
Dharmesh Vashee,
General Counsel, Federal Retirement Thrift
Investment Board.
[FR Doc. 2021–20976 Filed 9–27–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment for the
Chicago Breast Cancer Quality
Consortium
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of delisting.
AGENCY:
The Patient Safety and
Quality Improvement Final Rule
(Patient Safety Rule) authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a patient safety organization (PSO) an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient
Safety Rule, when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason, or when a PSO’s
listing expires. AHRQ accepted a
notification of proposed voluntary
relinquishment from the Chicago Breast
Cancer Quality Consortium, PSO
number P0074, of its status as a PSO,
and has delisted the PSO accordingly.
DATES: The delisting was effective at
12:00 Midnight ET (2400) on September
14, 2021.
ADDRESSES: The directories for both
listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. Both
directories can be accessed
electronically at the following HHS
website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT:
Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
E:\FR\FM\28SEN1.SGM
28SEN1
Federal Register / Vol. 86, No. 185 / Tuesday, September 28, 2021 / Notices
Background
The Patient Safety Act, 42 U.S.C.
299b–21 to 299b–26, and the related
Patient Safety Rule, 42 CFR part 3,
published in the Federal Register on
November 21, 2008 (73 FR 70732–
70814), establish a framework by which
individuals and entities that meet the
definition of provider in the Patient
Safety Rule may voluntarily report
information to PSOs listed by AHRQ, on
a privileged and confidential basis, for
the aggregation and analysis of patient
safety work product.
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
PSOs.
AHRQ has accepted a notification of
proposed voluntary relinquishment
from the Chicago Breast Cancer Quality
Consortium to voluntarily relinquish its
status as a PSO. Accordingly, the
Chicago Breast Cancer Quality
Consortium, P0074, was delisted
effective at 12:00 Midnight ET (2400) on
September 14, 2021.
Chicago Breast Cancer Quality
Consortium has patient safety work
product (PSWP) in its possession. The
PSO will meet the requirements of
section 3.108(c)(2)(i) of the Patient
Safety Rule regarding notification to
providers that have reported to the PSO
and of section 3.108(c)(2)(ii) regarding
disposition of PSWP consistent with
section 3.108(b)(3). According to section
3.108(b)(3) of the Patient Safety Rule,
the PSO has 90 days from the effective
date of delisting and revocation to
complete the disposition of PSWP that
is currently in the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO website
at https://www.pso.ahrq.gov.
VerDate Sep<11>2014
16:35 Sep 27, 2021
Jkt 253001
Dated: September 23, 2021.
Marquita Cullom,
Associate Director.
[FR Doc. 2021–21072 Filed 9–27–21; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Rescission of Humanitarian Exemption
for All Afghan Evacuees Subject to
CDC’s Global Testing Order
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces
rescission of the temporary
humanitarian exemption to the agency’s
Requirement for Negative Pre-Departure
COVID–19 Test Result, which was
previously granted for individuals
relocating to the United States from
Afghanistan (‘‘Afghan Evacuees’’),
including U.S. citizens, lawful
permanent residents (LPRs), third
country nationals, and Afghans at risk,
including Afghan Special Immigrant
Visa (SIV) applicants.
DATES: This temporary humanitarian
exemption to the Global Testing Order
was rescinded September 20, 2021.
FOR FURTHER INFORMATION CONTACT:
Tiffany Brown, Deputy Chief of Staff,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–10, Atlanta, GA 30329. Phone:
404–639–7000. Email: cdcregulations@
cdc.gov.
SUPPLEMENTARY INFORMATION: On
January 12, 2021, CDC issued an Order
requiring all air passengers arriving to
the U.S. from a foreign country to get
tested no more than 3 days before their
flight departs and to present the
negative result or documentation of
having recovered from COVID–19 to the
airline or aircraft operator before
boarding the flight. A copy of the Order
was published in the Federal Register
on January 21, 2021 (86 FR 6337) and
went into effect January 26, 2021.
In August 2021, the U.S. Department
of State (DOS) issued a series of Security
Alerts for Afghanistan due to increased
Taliban activity throughout the country,
including the capital of Kabul. In
response to a request from DOS on
August 15, 2021, CDC and the U.S.
Department of Health and Human
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
53659
Services (HHS) granted a blanket
humanitarian exemption to CDC’s Order
to expedite the evacuation of U.S.
citizens, lawful permanent residents
(LPRs), third country nationals, and
Afghans at risk, including Afghan
Special Immigrant Visa (SIV) applicants,
while adhering to other COVID–19
mitigation guidance issued by CDC.
The exemption, which is being
administered with the assistance of DOS
and other cooperating Federal and state
agencies, was granted with the
following conditions: (1) The CDC Order
requiring mask use for passengers and
crew on air conveyances bound for the
United States should be followed to the
extent possible; (2) all efforts should be
made to test for COVID–19 at a transit
location prior to arrival in the United
States, and to provide test
documentation to the traveler, which
can be presented upon arrival, and if
this cannot be done, individuals
(travelers) arriving are required to
undergo COVID–19 testing immediately
upon arrival to the first port of entry in
the United States; (3) individuals who
test positive are required to isolate prior
to continuing on commercial
transportation to their final destination;
and (4) family members of those testing
positive may be required to adhere to
self-quarantine recommendations as
stipulated by CDC or state and local
health authorities at the arrival location.
Beginning September 20, 2021, all
Afghan Evacuees arriving in the United
States will have to meet negative predeparture COVID–19 test requirements
or documentation of recovery. This
means evacuees will need to be tested
no more than three days before
departure to the United States and be
able to present the negative result or
provide documentation of having
recovered from COVID–19 within the
last 90 days, to the airline or aircraft
operator and upon request of United
States Government authorities on arrival
in the United States.
This requirement applies to all
Afghan Evacuees arriving in the United
States on any flight including U.S.
Government-owned or -contracted,
commercial, private, and general and
business aviation (chartered) flights
coming to the United States.
CDC is rescinding the humanitarian
exemption because:
• The Department of State (DOS) has
completed the emergency evacuation
and concluded the transport of evacuees
out of Afghanistan;
• With DOS’s conclusion of
emergency evacuation from
Afghanistan, there is a need to resume
appropriate health interventions,
including pre-departure COVID–19
E:\FR\FM\28SEN1.SGM
28SEN1
]]>Agencies
[Federal Register Volume 86, Number 185 (Tuesday, September 28, 2021)]
[Notices]
[Pages 53658-53659]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21072]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment for the
Chicago Breast Cancer Quality Consortium
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Final Rule (Patient
Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to
list as a patient safety organization (PSO) an entity that attests that
it meets the statutory and regulatory requirements for listing. A PSO
can be ``delisted'' by the Secretary if it is found to no longer meet
the requirements of the Patient Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses
to voluntarily relinquish its status as a PSO for any reason, or when a
PSO's listing expires. AHRQ accepted a notification of proposed
voluntary relinquishment from the Chicago Breast Cancer Quality
Consortium, PSO number P0074, of its status as a PSO, and has delisted
the PSO accordingly.
DATES: The delisting was effective at 12:00 Midnight ET (2400) on
September 14, 2021.
ADDRESSES: The directories for both listed and delisted PSOs are
ongoing and reviewed weekly by AHRQ. Both directories can be accessed
electronically at the following HHS website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local):
(301) 427-1130; Email: [email protected].
SUPPLEMENTARY INFORMATION:
[[Page 53659]]
Background
The Patient Safety Act, 42 U.S.C. 299b-21 to 299b-26, and the
related Patient Safety Rule, 42 CFR part 3, published in the Federal
Register on November 21, 2008 (73 FR 70732-70814), establish a
framework by which individuals and entities that meet the definition of
provider in the Patient Safety Rule may voluntarily report information
to PSOs listed by AHRQ, on a privileged and confidential basis, for the
aggregation and analysis of patient safety work product.
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
attests that it meets the statutory and regulatory requirements for
listing. A PSO can be ``delisted'' if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of PSOs.
AHRQ has accepted a notification of proposed voluntary
relinquishment from the Chicago Breast Cancer Quality Consortium to
voluntarily relinquish its status as a PSO. Accordingly, the Chicago
Breast Cancer Quality Consortium, P0074, was delisted effective at
12:00 Midnight ET (2400) on September 14, 2021.
Chicago Breast Cancer Quality Consortium has patient safety work
product (PSWP) in its possession. The PSO will meet the requirements of
section 3.108(c)(2)(i) of the Patient Safety Rule regarding
notification to providers that have reported to the PSO and of section
3.108(c)(2)(ii) regarding disposition of PSWP consistent with section
3.108(b)(3). According to section 3.108(b)(3) of the Patient Safety
Rule, the PSO has 90 days from the effective date of delisting and
revocation to complete the disposition of PSWP that is currently in the
PSO's possession.
More information on PSOs can be obtained through AHRQ's PSO website
at https://www.pso.ahrq.gov.
Dated: September 23, 2021.
Marquita Cullom,
Associate Director.
[FR Doc. 2021-21072 Filed 9-27-21; 8:45 am]
BILLING CODE 4160-90-P
